ATG Inc. Announces Initial Public Offering.FREMONT, Calif.--(BUSINESS WIRE)--May 7, 1998--ATG Inc. announced today the initial public offering of 1,900,000 shares of Common Stock at a price of $8.50 per share. Van Kasper & Company is the managing underwriter Managing underwriter The leading firm in an underwriting group, which originates the deal and acts as an agent for the group. managing underwriter See lead underwriter. of the offering. All of the shares are being sold by the Company. ATG ATG antithymocyte globulin. lymphocyte immune globulin (antithymocyte globulin equine, ATG, ATG equine, LIG) Atgam Pharmacologic class: Immunoglobulin Therapeutic class: Immunosuppressant Inc. is a radioactive and hazardous waste management company that offers comprehensive treatment solutions for low-level radioactive waste Noun 1. low-level radioactive waste - (medicine) radioactive waste consisting of objects that have been briefly exposed to radioactivity (as in certain medical tests) and low-level mixed waste generated by the U.S. Departments of Defense and Energy, as well as commercial entities such as nuclear power plants, medical facilities and research institutions. A copy of the final prospectus may be obtained from the offices of Van Kasper & Company at 600 California Street, Suite 1700, San Francisco, California “San Francisco” redirects here. For other uses, see San Francisco (disambiguation). The City and County of San Francisco (EN IPA: [sænfrənˈsɪskoʊ] 94108. CONTACT: Steven J. Guerrettaz, 510/490-3008 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion